New brain zapping technique could help Parkinson's patients move better
NCT ID NCT07018388
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called NervioX-2400 that uses weak electrical currents to stimulate specific brain areas without surgery. Researchers want to see if it can improve movement problems like tremors and stiffness in 100 people with early-to-mid stage Parkinson's disease. Each participant will try two different stimulation targets to compare which works better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
temporal interference stimulation (tTIS) via the NervioX-2400 device
What this could lead to
If successful, this could point toward a non-invasive, drug-free way to temporarily ease motor symptoms like tremor and stiffness in Parkinson's disease.
What could go wrong
This is an early-stage, non-randomized study with no placebo control, so results may not be conclusive. The effects are measured only during 'off' medication states and may not translate to real-world benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital
Shanghai, Shanghai Municipality, China, China